CKM Syndrome Reveals 90% of Americans Are on a Heart–Kidney–Metabolic Risk Path
TL;DR
CKM syndrome, formalized by the AHA in 2023, is a four-stage framework showing how overweight, high blood pressure, high blood sugar, and reduced kidney function connect cardiovascular, kidney, and metabolic diseases; about 90% of U.S. adults fall somewhere on the spectrum, from risk (Stage 0) to overt disease, with prevention centered on lifestyle changes and newer medications like GLP-1s, SGLT2 inhibitors, and nsMRAs that benefit multiple organs.
- 90 percent of U.S. adults have this syndrome — but most have never heard of it The Washington Post
- From PMOS to CKM: The silent metabolic crisis behind new disease names The Indian Express
- Cardiovascular–kidney–metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management springermedicine.com
- CKM Guidelines: A Nephrologist’s Perspective on Preventive Care MedCentral
- What is cardiovascular-kidney-metabolic (CKM) syndrome? Symptoms causes risk factors and new AHA guidelines explained TheHealthSite
Want the full story? Read the original reporting
Read on The Washington Post